X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (87) 87
hematology (63) 63
index medicus (60) 60
female (46) 46
male (43) 43
middle aged (41) 41
adult (40) 40
bortezomib (35) 35
multiple myeloma (32) 32
aged (28) 28
multiple myeloma - drug therapy (28) 28
treatment outcome (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
oncology (23) 23
dexamethasone (18) 18
stem-cell transplantation (17) 17
transplantation (17) 17
care and treatment (16) 16
boronic acids - therapeutic use (15) 15
pyrazines - therapeutic use (15) 15
recurrence (15) 15
antineoplastic agents - therapeutic use (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
stem cells (14) 14
clinical trials (13) 13
disease-free survival (13) 13
multiple myeloma - therapy (13) 13
thalidomide (13) 13
therapy (13) 13
boronic acids - adverse effects (12) 12
chemotherapy (12) 12
dexamethasone - therapeutic use (12) 12
multiple myeloma - mortality (12) 12
pyrazines - adverse effects (12) 12
boronic acids - administration & dosage (11) 11
lenalidomide (11) 11
leukemia (11) 11
pyrazines - administration & dosage (11) 11
remission induction (11) 11
abridged index medicus (10) 10
adolescent (10) 10
animals (10) 10
cancer (10) 10
dexamethasone - administration & dosage (10) 10
relapse (10) 10
antineoplastic agents - adverse effects (9) 9
diseases (9) 9
drug administration schedule (9) 9
follow-up studies (9) 9
hematopoietic stem cell transplantation (9) 9
hemic and lymphatic diseases (9) 9
myeloma (9) 9
stem cell transplantation (9) 9
survival analysis (9) 9
aml (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
dexamethasone - adverse effects (8) 8
immunosuppressive agents - therapeutic use (8) 8
mice (8) 8
mutation (8) 8
prognosis (8) 8
aged, 80 and over (7) 7
diagnosis (7) 7
kaplan-meier estimate (7) 7
lenalidomide plus dexamethasone (7) 7
leukemia, myeloid, acute - pathology (7) 7
melphalan - administration & dosage (7) 7
refractory myeloma (7) 7
risk (7) 7
survival (7) 7
transplantation, autologous (7) 7
transplantation, homologous (7) 7
trial (7) 7
young adult (7) 7
bone-marrow-transplantation (6) 6
combined modality therapy (6) 6
doxorubicin - administration & dosage (6) 6
hematology, oncology and palliative medicine (6) 6
leukemia, myeloid, acute - drug therapy (6) 6
leukemia, myeloid, acute - genetics (6) 6
leukemia, myeloid, acute - mortality (6) 6
multiple myeloma - complications (6) 6
multiple myeloma - pathology (6) 6
survival rate (6) 6
thalidomide - analogs & derivatives (6) 6
transplants & implants (6) 6
acute myeloid leukaemia (5) 5
acute myeloid-leukemia (5) 5
antineoplastic agents - administration & dosage (5) 5
antineoplastic agents - pharmacology (5) 5
article (5) 5
blood (5) 5
bone marrow (5) 5
child (5) 5
combination (5) 5
cyclophosphamide (5) 5
disease progression (5) 5
dose-response relationship, drug (5) 5
drug therapy (5) 5
drug therapy, combination (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1195 - 1206
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 874 - 885
Summary Background Relapsed multiple myeloma has no standard treatment, and the role of autologous stem-cell transplantation (ASCT) has not been fully defined.... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE | SUPERIORITY | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | IMPACT | METAANALYSIS | ONCOLOGY | CLINICAL-TRIALS | LENALIDOMIDE | SALVAGE THERAPY | INDUCTION | MARROW TRANSPLANTATION | Recurrence | Cyclophosphamide - administration & dosage | Peripheral Nervous System Diseases - chemically induced | Consolidation Chemotherapy - methods | Humans | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Multiple Myeloma - therapy | Time Factors | Adult | Female | Boronic Acids - administration & dosage | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Proportional Hazards Models | Thrombocytopenia - chemically induced | Disease Progression | Induction Chemotherapy - adverse effects | Retreatment | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged | Multiple Myeloma - genetics | Stem Cell Transplantation - adverse effects | Care and treatment | Relapse | Multiple myeloma | Clinical trials | Transplantation | Diseases | Cyclophosphamide | Chemotherapy | Hospitals | Stem cells | Dosage and administration | Product development | Cancer
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 58 - 58
Abstract Background Loss of immune surveillance is thought to contribute to disease progression and treatment resistance in a range of malignancies including... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 906 - 917
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2004, Volume 351, Issue 23, pp. 2403 - 2407
A father and two of his children were found to have acute myeloid leukemia (AML) and an identical germ-line mutation in the CEBPA gene. The product of this... 
Prognosis | CCAAT-Enhancer-Binding Protein-beta - genetics | Humans | Male | CCAAT-Enhancer-Binding Protein-beta - chemistry | DNA Mutational Analysis | Pedigree | Base Sequence | Adolescent | Germ-Line Mutation | Adult | Female | Mutation | Child | Leukemia, Myeloid, Acute - genetics | Proteins | Genetics | Medical diagnosis | Leukemia
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2005, Volume 352, Issue 24, pp. 2487 - 2498
Journal Article
Clinical medicine (London, England), ISSN 1470-2118, 06/2015, Volume 15, Issue 3, pp. 292 - 294
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2016, Volume 172, Issue 2, pp. 187 - 207
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2017, Volume 23, Issue 21, pp. 6430 - 6440
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2013, Volume 110, Issue 33, pp. 13576 - 13581
Journal Article